This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 pounds or more, and this month it approved a lower dose spray for ...

The U.S. Food and Drug Administration approved the local company’s 1 milligram dose of epinephrine nasal spray on Wednesday. It’s geared toward patients 4 years and older who weigh at least 33 ...

$7.3 million in total neffy® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...

$7.3 million in total neffy® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...

$7.3 million in total neffy ® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...

The U.S. Food and Drug Administration approved the local company’s 1 milligram dose of epinephrine nasal spray on Wednesday. It’s geared toward patients 4 years and older who weigh at least 33 ...

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) is a biopharmaceutical company focused on developing neffy, a needle-free epinephrine nasal spray designed to treat severe allergic reactions, including ...

$7.3 million in total neffy® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...